SCIENTIFIC publications
The public health emergency provoked by the COVID-19 pandemic is paralleled by an economic and social crisis to which, according to research, patients with rheumatic and musculoskeletal diseases are particularly vulnerable.
Assessment of the Impact of the COVID-19 Pandemic on People with Rheumatic Diseases in Europe
Menú
Country: Europe Date: June 2-5th 2021
Assessment of the COVID-19 Pandemic from the Perspective of People with Rheumatic Musculoskeletal Diseases in Europe. Results from the first phase of the REUMAVID study.
Country Comparison on the Impact of the COVID-19 Pandemic on Patients with Rheumatic Diseases. Results from the REUMAVID Study (Phase 1)
Gender differences on the Impact of the COVID-19 Pandemic and Lockdown in Patients with Rheumatic Diseases. Results from the REUMAVID Study (Phase 1)
Impact of the COVID-19 Pandemic and Lockdown on Wellbeing on Patients with Rheumatic Diseases. Results from the REUMAVID Study (Phase 1)
Fears and Hopes during the COVID-19 Pandemic in Patients with Rheumatic Diseases. Results from the REUMAVID Study (Phase 1)
Country: UK
Date: April 26-28th 2021
Evaluation of the impact of the COVID-19 pandemic on patients with rheumatic diseases in the UK: results from the REUMAVID study
Country: France
Evaluation of the impact of the COVID-19 pandemic on patients with rheumatic diseases in the UK: results from the REUMAVID study
Conference: ACR 2020 Country: USA Date: May, 19-22th 2020
Assessment of the COVID-19 Pandemic from the Perspective of People with Rheumatic Musculoskeletal Diseases in Europe. Preliminary Results from the REUMAVID Study
Country: Spain
Date: December 13-16th 2020
Evaluación del impacto de la pandemia COVID-19 en pacientes con enfermedades reumáticas y musculoesqueléticas en España. Resultados del estudio REUMAVID
REUMAVID is a project conducted by the Health & Territory Research (HTR) group of the University of Seville (Spain)
